RENACIDIN IRRIGATION Rx
Generic Name and Formulations:
Citric acid 6.602g, glucono-delta-lactone 198mg, magnesium carbonate 3.177g; per 100mL; irrigation soln (pH 3.85).
Indications for RENACIDIN IRRIGATION:
Dissolution of renal or bladder calculi composed of apatite or struvite in select patients. Adjunct to dissolve apatite or struvite calculi after surgery or to achieve partial dissolution prior to surgical removal. Prevention of incrustations of indwelling urinary tract catheters.
Renal calculi: Irrigate with sterile saline at 60mL/hr after fourth or fifth post-operative day and increase until pain, elevated pressure or a maximum of 120mL/hr is achieved; then start Renacidin at max rate achieved with saline. Bladder calculi: 30mL through urinary catheter into bladder, clamp for 30–60 minutes, drain bladder; repeat 4–6 times a day. Catheter incrustation: 30mL through catheter, clamp for 10 minutes, drain; repeat 3 times daily.
UTIs (obtain urine culture prior to use). Urinary tract extravasation.
Monitor magnesium, phosphate, serum creatinine, intrapelvic pressure, and for UTI or catheter obstruction; discontinue if these increase or severe urothelial edema on X-ray occur. Impaired renal function. Maintain catheter patency. Elderly. Pregnancy (Cat.C). Nursing mothers.
Concomitant magnesium: not recommended.
Transient flank pain, urthelial ulceration and/or edema, fever, UTI, back pain, dysuria, transient hematuria, nausea, hypermagnesemia, hyperphosphatemia, elevated serum creatinine, candidiasis, bladder irritation.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|